Dn. Criddle et al., VASODILATOR ACTION OF THE ISOPROPYL ESTER OF PALMITOYL CARNITINE IN THE RAT CORONARY CIRCULATION AND MESENTERIC VASCULAR BED, European journal of pharmacology, 255(1-3), 1994, pp. 223-228
The vasodilator action of the isopropyl ester of palmitoyl carnitine (
P1Pi) has been examined in perfused rat hearts and mesenteric vessels.
The coronary vasodilator effect P1Pi was not significantly inhibited
by flurbiprofen (10 mu M), BW755C (10 mu M), glibenclamide (10 mu M) o
r the bradykinin B-2 receptor antagonist D-Arg(0)[Hyp(3),Thi(5,8),D-Ph
e(7)]bradykinin (1 mu M), indicating that the action of P1Pi is not me
diated via arachidonic acid metabolites, ATP-dependent K+ channels or
bradykinin B-2 receptors. L-NG-Nitro arginine (100 mu M) did not inhib
it the vasodilator action of P1Pi whilst superoxide dismutase (20 and
50 Uml(-1)) attenuated its vasodilator action. Methylene blue (10 mu M
) caused inhibition in three out of four hearts, while haemoglobin (1
mu M) caused an irreversible inhibition of the action of P1Pi which wa
s associated with a depression of myocardial contractility. In air-dam
aged mesenteric vascular beds the vasodilator action of P1Pi was not a
ttenuated, whilst that of acetylcholine was abolished. In K+-depolaris
ed mesenteric vascular beds the constrictor action of Ca2+ was attentu
ated by P1Pi. Therefore the vasodilator effect of P1Pi appears to be t
he result of a direct effect on smooth muscle.